Stool test study for Lynch syndrome colon screening
Part of Cancer, Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests a new stool-based test (FIT) to see if it can help find colon cancer early in people with Lynch syndrome. You will collect stool samples at home and complete surveys before your regular colonoscopy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed genetic change in MLH1, MSH2, MSH6, PMS2, or EPCAM that causes Lynch syndrome.
- You are between 20 and 80 years old (if you have MLH1, MSH2, or EPCAM) or between 30 and 80 (if you have PMS2 or MSH6).
- You have an upcoming colonoscopy scheduled as part of your routine Lynch syndrome care.
- If you had colon surgery, you still have at least 20 centimeters of colon left.
- You are willing to collect stool samples and fill out surveys.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study looks at how many people with colon cancer also have Lynch syndrome, an inherited condition that can affect cancer risk. If you enroll, your care team collects basic information from your diagnosis to better estimate how common it is.
This study tests if a stool microbiome test can help find colorectal cancer early in people who already had a positive FIT screening test. You would give a stool sample and your microbiome results will be compared to what the colonoscopy finds.
This trial tests a new stool-based screening test that may find colorectal cancer and advanced adenomas (precancerous growths) early. It studies whether the test works well compared with the standard colonoscopy, so it could offer an easier, less invasive screening option in the future.
This study collects blood and stool samples to see how well they can detect colorectal cancer or advanced growths in people with Lynch syndrome (an inherited colon cancer risk) or suspected Lynch syndrome. It may help find cancer or precancer earlier, which can improve next-step decisions.
This study tests a stool-based DNA test for people with Lynch syndrome. It aims to find colorectal cancer early by checking stool samples for specific DNA changes, so you can catch problems sooner and get the right care.
This study is testing whether a simple blood test can safely replace some of the more invasive procedures used to monitor people with Lynch syndrome, a condition that increases the risk of certain cancers (especially colorectal and uterine). If the blood test works as well, it could mean fewer colonoscopies and other invasive tests for those with Lynch syndrome.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.